Summary
- Current Price
- As of today, AKTS price is $24.93, up +4.79% on
- Current Price All-Time High
- AKTS price is currently -27.08% below its historical high of $34.19 set on
- Market Cap
- AKTS current market cap is $1B
- Revenue
- AKTS current annual revenue is $6.50M, up +336.92% year-over-year
- Next Earnings
- As of today, the next earnings release for AKTS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Aktis Oncology, Inc. |
| Ticker | NASDAQ: AKTS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aktisoncology.com |
| Employees | 79 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $24.93 | |
| Price, 1D Change | +4.79% | |
| $1B | ||
| - | ||
| - | ||
| 1.61 | ||
| $6.50M | ||
| Revenue, 1Y Change | +336.92% | |
| -$1.19 | ||
| EPS, 1Y Change | -42.51% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | DNLX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.19 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $6.50M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $24.93 | |
| Price Target | $33.50 | - |
| Price Tgt. Change | +34.38% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.87 | -$1.19 | +69.16% | |
| - | N/A | - | |
| -$1.62 | N/A | -35.76% | |
| -$1.97 | N/A | -64.84% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.91M | $6.50M | -6.02% | |
| - | N/A | - | |
| $10.70M | N/A | +64.64% | |
| $11.55M | N/A | +77.77% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $24.93 | |
| $21.05 | ||
| $24.54 | ||
| - | ||
| $23.81 | ||
| -$0.26 | ||
| 1.61 | ||
| $1.59 | ||
| 54.59 | ||
| 41.90% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $6.50M | ||
| -$1.19 | ||
| $4.17M | ||
| 64.15% | ||
| -$74.68M | ||
| -1,149.52% | ||
| -$63.73M | ||
| -980.93% | ||
| -$72.36M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.06 | ||
| 7.37 | ||
| 7.37 | ||
| - | ||
| 6 | ||
| 9.18 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 270.37 | ||
| 2.72 | ||
| -21.97 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$146.15M | ||
| $226.79M | ||
| $270.01M | ||
| $230.31M | ||
| $82.75M | ||
| $31.24M | ||
| $11.55M | ||
| $1.32M | ||
| $1.74M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $70.23M | ||
| $78.85M | ||
| $2.33M | ||
| $0.00 | ||
| $2.33M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$64.13M | ||
| $65.96M | ||
| -$1.21M | ||
| $9.58M | ||
| -$73.71M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| Raymond James | ||
| HC Wainwright & Co. | → | |
| William Blair | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Leerink Partners | ||
| JP Morgan | ||
| Piper Sandler | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with AKTS
FAQ
- What is the ticker symbol for Aktis Oncology, Inc.?
- The ticker symbol for Aktis Oncology, Inc. is NASDAQ:AKTS
- Does Aktis Oncology, Inc. pay dividends?
- No, Aktis Oncology, Inc. does not pay dividends
- What sector is Aktis Oncology, Inc. in?
- Aktis Oncology, Inc. is in the Healthcare sector
- What industry is Aktis Oncology, Inc. in?
- Aktis Oncology, Inc. is in the Biotechnology industry
- What country is Aktis Oncology, Inc. based in?
- Aktis Oncology, Inc. is headquartered in United States
- When did Aktis Oncology, Inc. go public?
- Aktis Oncology, Inc. initial public offering (IPO) was on January 9, 2026
- Is Aktis Oncology, Inc. in the S&P 500?
- No, Aktis Oncology, Inc. is not included in the S&P 500 index
- Is Aktis Oncology, Inc. in the NASDAQ 100?
- No, Aktis Oncology, Inc. is not included in the NASDAQ 100 index
- Is Aktis Oncology, Inc. in the Dow Jones?
- No, Aktis Oncology, Inc. is not included in the Dow Jones index
- When was Aktis Oncology, Inc. last earnings report?
- Aktis Oncology, Inc.'s most recent earnings report was on August 13, 2026
- When does Aktis Oncology, Inc. report earnings?
- The date for Aktis Oncology, Inc.'s next earnings report has not been announced yet
Data Sources & References
- AKTS Official Website www.aktisoncology.com
- AKTS Profile on Yahoo Finance finance.yahoo.com/quote/AKTS
- AKTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/akts